Evidence map›Paper›PMID 22393132›Full record

ArticleAnnals of internal medicine2012

What comparative effectiveness research is needed? A framework for using guidelines and systematic reviews to identify evidence gaps and research priorities.

Tianjing Li, S Swaroop Vedula, Roberta Scherer, Kay Dickersin

Abstract read
In one paragraph

Article in Annals of internal medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Effectiveness of interventions for reducing TB incidence in countries with low TB incidence: a systematic review of reviews.European respiratory review : an official journal of the European Respiratory Society · 2019
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Topical medication instillation techniques for glaucoma.The Cochrane database of systematic reviews · 2017
    Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. From clinical practice guideline development to trial registration: A systematic investigation of research pipeline for inflammatory bowel disease.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2019
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tianjing LiCenter for Clinical Trials, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA. tli@jhsph.edu
S Swaroop Vedula
Roberta Scherer
Kay Dickersin

Funding

Comparative Effectiveness Research & the Cochrane Eyes & Vision GroupU01EY020522 · NEI · JOHNS HOPKINS UNIVERSITY · PI DICKERSIN, KAY · 2010 to 2016
$9.2M
COCHRANE EYE AND VISION GROUP-COORDINATING RESOURCE CENTER-260021003N01EY021003 · NEI · JOHNS HOPKINS UNIVERSITY · PI DICKERSIN, KAY · 2006 to 2006
–
NEI NIH HHS N01 EY021003NEI NIH HHS N01-EY2-1003NEI NIH HHS U01 EY020522NEI NIH HHS U01-EY020522-01
6 · The paper itself

Abstract

The authors developed and tested a framework for identifying evidence gaps and prioritizing comparative effectiveness research by using a combination of clinical practice guidelines and systematic reviews. In phase 1 of the project, reported elsewhere, 45 clinical questions on the management of primary open-angle glaucoma were derived from practice guidelines and prioritized by using a 2-round Delphi survey of clinicians. On the basis of the clinicians' responses, 9 questions were classified as high-priority. In phase 2, reported here, systematic reviews that addressed the 45 clinical questions were identified. The reviews were classified as at low, high, or unclear risk of bias, and evidence gaps (in which no systematic review was at low risk of bias) were identified. The following comparative effectiveness research agenda is proposed: Two of the 9 high-priority questions require new primary research (such as a randomized, controlled trial) and 4 require a new systematic review. The utility and limitations of the framework and future adaptations are discussed.

Indexed as

Evidence-Based MedicineReview Literature as TopicComparative Effectiveness ResearchGlaucoma, Open-AngleHumansPractice Guidelines as TopicRandomized Controlled Trials as TopicResearch DesignSurveys and Questionnaires

Identifiers

PMID22393132
PMCPMC3804310

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.